FTXH ETF (First Trust Nasdaq Pharmaceuticals ETF) is managed by First Trust Portfolios (US) with $34.2M in net assets. FTXH expense ratio is 0.60%, holding 51 positions across sectors including Health Care, Unknown, Other. Inception date: 2016-09-20.

FTXH performance shows a YTD return of 6.98%. The 1-year return is 38.51% and the 5-year return is 7.66%. FTXH dividend yield stands at 1.20%, paid quarterly.

FTXH top holdings include Bristol-Myers Squibb Co. (7.2%), Eli Lilly and Co. (7.1%), Johnson & Johnson (7.0%), Merck & Co Inc (7.0%), Abbvie Inc Accenture Plc, Class A (6.9%). View all FTXH holdings, sector breakdown, or dividend history.

FTXH can be compared against other funds using the overlap calculator or side-by-side comparison tool. FTXH alternatives are available via the screener, along with tax-loss harvesting opportunities.